AbbVie to buy Pharmacyclics in $21 billion deal

Reuters News
|
Posted: Mar 04, 2015 11:04 PM

(Reuters) - AbbVie Inc <ABBV.N> said it will buy cancer drug company Pharmacyclics Inc <PCYC.O> in a $21 billion deal.

AbbVie will pay $261.25 per share in cash and stock for Pharmacyclics.

(Reporting by Supriya Kurane in Bengaluru; Editing by Gopakumar Warrier)